Advanced Malignant Cancer

Oncology
2
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

CT
2 programs
2
TQB3019 capsulesPhase 11 trial
TQB3117 tabletsPhase 11 trial
Active Trials
NCT06943677RecruitingEst. Dec 2028
NCT06415903Not Yet RecruitingEst. Aug 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
Chia Tai TianQing Pharmaceutical GroupTQB3019 capsules
Chia Tai TianQing Pharmaceutical GroupTQB3117 tablets

Clinical Trials (2)

A Clinical Trial on the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TQB3019 Capsule in Subjects With Advanced Malignant Tumors

Start: May 2025Est. completion: Dec 2028
Phase 1Recruiting

A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer

Start: Jun 2024Est. completion: Aug 2026
Phase 1Not Yet Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space